Patents by Inventor Franck Chaubron

Franck Chaubron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8993333
    Abstract: Disclosed is a method of providing a risk evaluation and diagnosis of human cancer, by examining the presence, in the volatile fraction of a human saliva sample, of a combination of particulate biochemical volatile organic compounds, which is indicative of an increased risk of developing cancer.
    Type: Grant
    Filed: August 3, 2010
    Date of Patent: March 31, 2015
    Assignee: Institut Clinident
    Inventor: Franck Chaubron
  • Publication number: 20140065600
    Abstract: A method of providing a risk evaluation and diagnosis of human oral cancer, by examining at the presence in human saliva sample of a combination of particulate nucleic acids from bacteria, virus, as well as human, and/or the presence of particulate biochemical volatile organic compounds, which are indicative of an increased risk of oral cancer.
    Type: Application
    Filed: August 23, 2013
    Publication date: March 6, 2014
    Applicant: Institut Clinident
    Inventor: Franck CHAUBRON
  • Publication number: 20120126111
    Abstract: Disclosed is a method of providing a risk evaluation and diagnosis of human cancer, by examining the presence, in the volatile fraction of a human saliva sample, of a combination of particulate biochemical volatile organic compounds, which is indicative of an increased risk of developing cancer.
    Type: Application
    Filed: August 3, 2010
    Publication date: May 24, 2012
    Inventor: Franck Chaubron
  • Publication number: 20110143962
    Abstract: A method of providing a risk evaluation and diagnosis of human oral cancer, by examining at the presence in human saliva sample of a combination of particulate nucleic acids from bacteria, virus, as well as human, and/or the presence of particulate biochemical volatile organic compounds, which are indicative of an increased risk of oral cancer.
    Type: Application
    Filed: August 3, 2009
    Publication date: June 16, 2011
    Applicant: INSTITUT CLINIDENT
    Inventor: Franck Chaubron
  • Publication number: 20060257871
    Abstract: This invention is related to a novel sample preparation, probes, couple primer sets for one step real time reverse transcriptase polymerise chain reaction (RT-PCR), methods and kits for the universal detection of alive bacteria and/or fungus-yeast in pharmaceutical, cosmetic and non clinical samples.
    Type: Application
    Filed: November 3, 2003
    Publication date: November 16, 2006
    Inventors: Franck Chaubron, Anne Martin -Minvielle, Sophie Groulon
  • Patent number: 6605435
    Abstract: A method of amplifying all of the DNA fragments of a sample, including fragments that are small or damaged, comprises an initial step of generating free 3′-OH end with P1 nuclease. The method also provides for extraction of the DNA fragments from a sample and reduction of their size to between 100 and 300 base pairs. A poly(dX) oligonucleotide is added to the 3′ ends of the DNA fragments using a terminal transferase, and the DNA is denatured and hybridized to a poly(dY) primer complementary to the poly(dX) ends. Finally, the DNA is polymerized with DNA polymerase. The resulting DNA can be amplified by denaturing and slowly renaturing the complementary strands.
    Type: Grant
    Filed: March 2, 2001
    Date of Patent: August 12, 2003
    Assignee: Genolife
    Inventors: Christian Provot, Franck Chaubron, Anne-CĂ©line Martin
  • Patent number: 6309838
    Abstract: The invention concerns a method for detecting impairment of DNA comprising contacting a sample DNA with a composition comprising at least one recognition protein selected from the group consisting of proteins belonging to the nucleotide excision repair system, proteins belonging to the base excision repair system, and proteins belonging to the system for detecting DNA breaks and detecting a complex formed between the recognition protein and DNA to thereby detect impairment of the DNA sequence.
    Type: Grant
    Filed: November 19, 1999
    Date of Patent: October 30, 2001
    Assignee: Genolife
    Inventors: Franck Chaubron, Christian Provot